Document is current
Any future updates will be listed below
-
Authors
Geven, Christopher
Pickkers, Peter http://orcid.org/0000-0002-1104-4303
- License Information
-
More Information
Article History
Received: 30 April 2018
Accepted: 21 May 2018
First Online: 13 June 2018
Competing interests
: C. Geven received travel reimbursements from Adrenomed AG (the company that developed Adrecizumab). P. Pickkers received travel reimbursements and consultancy fees from Adrenomed AG. P. Pickkers’s institution received a research grant from Adrenomed AG.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
